SDC2 and Alzheimer disease: In light of reported neuronal hyperexcitability in Alzheimer’s patients and models of Alzheimer’s disease [57,58], our work suggests that Aβ-HSPG interactions may affect the expression of HSPGs at the AIS, decreasing activation of CaMKII at the AIS and hence increasing neuronal excitability.